| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/25/2002 | WO2001059102A3 Nucleozymes with endonuclease activity |
| 04/25/2002 | WO2001058891A3 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 04/25/2002 | WO2001058450A3 Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation |
| 04/25/2002 | WO2001056552A3 Farnesyl protein transferase inhibitors for treating breast cancer |
| 04/25/2002 | WO2001052904A3 Pharmaceutical compositions and methods of treatment based on VEGF antisense oligonucleotides |
| 04/25/2002 | WO2001052830A3 METHODS TO TREAT α-1-ANTITRYPSIN DEFICIENCY |
| 04/25/2002 | WO2001052651A3 Particulate blends and compacted products formed therefrom, and the preparation thereof |
| 04/25/2002 | WO2001047913A3 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
| 04/25/2002 | WO2001047533A3 INHIBITION OF GSK-3$g(b) |
| 04/25/2002 | WO2001046327A3 1,1-disubstituted ethylene adhesive compositions containing polydimethylsiloxane |
| 04/25/2002 | WO2001045740A3 Compositions and methods for treatment of breast cancer |
| 04/25/2002 | WO2001045687A3 Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
| 04/25/2002 | WO2001043753A3 Combination of ginseng and ginkgo to improve cognitive skills |
| 04/25/2002 | WO2001041810A3 Nucleic acid delivery system |
| 04/25/2002 | WO2001034094A3 Novel compounds to treat diabetes and associated conditions |
| 04/25/2002 | WO2001028521A3 Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate |
| 04/25/2002 | WO2001010431A3 Headache and colic relief composition with asafetida and method of use thereof |
| 04/25/2002 | WO2001002369A3 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 04/25/2002 | US20020049389 Noninvasive measurement of chemical substances |
| 04/25/2002 | US20020049345 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 04/25/2002 | US20020049344 New vitamin d derivatives with carbo-or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments |
| 04/25/2002 | US20020049335 DNA alkylating compounds such as 1-(tert-butyloxycarbonyl) -4-hydroxy-3(((methane-sulfonyl)oxy)methyl)-2,3-dihydroindole |
| 04/25/2002 | US20020049329 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 04/25/2002 | US20020049328 Such as (R)-1-Cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxyl ic acid methanesulfonate; chemical intermediates; bactericides; catalysis |
| 04/25/2002 | US20020049327 Such as 7-(3-chlorophenyl)-9-((4-chlorophenyl)-1H-imidazol-1-ylmethyl)-2,3-dihydro -1H,5H-benzo(ij)quinolizin-5-one; for forming oncogenes for signalling transformation of tumor cells |
| 04/25/2002 | US20020049326 Benzosulfones and related compositions and methods |
| 04/25/2002 | US20020049325 Calcium channel blockers |
| 04/25/2002 | US20020049324 Topoisomerase inhibitors |
| 04/25/2002 | US20020049322 Quinoline and quinazoline compounds useful in therapy |
| 04/25/2002 | US20020049313 Method for introducing foreign material into higher eukaryotic cells |
| 04/25/2002 | US20020049299 Oxidizing and polymerizing aromatic compounds of at least one hydroxyl and carbonyl groups or at least two hydroxyl groups; humic acids |
| 04/25/2002 | US20020049281 Contacting with crosslinking agents so as to form two or more chemically distinct crosslinks between hyaluronic acid and the polymer; products with medical applications |
| 04/25/2002 | US20020049257 Possibly methoxylated norbornanyl-cyclohexanols; acne treatment; deodorant |
| 04/25/2002 | US20020049256 Anti- neoplastic, anti-diarrheal, anti-peristaltic, gastro-intestinal anti-spasmodic, anti-viral, anti-retroviral, anti-psoriasis and insecticidal compositions |
| 04/25/2002 | US20020049255 Method of treating neurodegenerative disorders of the retina and optic nerve head |
| 04/25/2002 | US20020049254 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease |
| 04/25/2002 | US20020049253 Structural or functional components of the creatine kinase/ phosphocreatine system sufficient to prevent, reduce or ameliorate skin damage or skin aging |
| 04/25/2002 | US20020049252 Methods, compositions and modes of delivery for the treatment of emphysema using 13-cis-retinoic acid |
| 04/25/2002 | US20020049251 Wedelolactone and its synthesis for treating neurodegenerative diseases |
| 04/25/2002 | US20020049250 PPAR receptor activator compounds for treating cutaneous disorders/afflictions |
| 04/25/2002 | US20020049249 PPAR receptor activator compounds for treating cutaneous disorders/afflictions |
| 04/25/2002 | US20020049248 Alone or in combination for treatment of adult-T-cell leukemia- lymphoma |
| 04/25/2002 | US20020049245 Tumor necrosis factor alpha (TNF-alpha) inhibiting pharmaceuticals |
| 04/25/2002 | US20020049244 Treatment of disease or disease symptoms mediated by eicosanoid 20-hydroxyeicosatetraenoic acid (20-HETE) a potent constrictor of renal, cerebral and skeletal muscle arterioles |
| 04/25/2002 | US20020049243 Pyrrolidine derivatives |
| 04/25/2002 | US20020049240 Novel compounds |
| 04/25/2002 | US20020049239 Novel indole and benzothiazole derivatives |
| 04/25/2002 | US20020049238 Heterocyclic-hydroxyimino-fluorene nuclei compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 04/25/2002 | US20020049237 Statin-MMP inhibitor combinations |
| 04/25/2002 | US20020049236 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/25/2002 | US20020049234 Inhibitors of factor Xa; for example 3-(4-tert-butylbenzoyl)amino-N-(4-methoxyphenyl)-2-thiophenecarboxamide |
| 04/25/2002 | US20020049233 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 04/25/2002 | US20020049232 Method of treating parkinson's disease |
| 04/25/2002 | US20020049231 S(-)-3-aminothalidomide; treating wide variety of diseases including diabetic retinopathy |
| 04/25/2002 | US20020049230 Administering reboxetine and derivatives to treat drug abuse, drug dependence, alcoholism, and tobacco/nicotine addiction, as well as Attention Deficit Hyperactivity Disorder (ADHD) |
| 04/25/2002 | US20020049226 Treating obesity, hyperlipidemia, glaucoma, arrhythmia, skin disorders, thyroid disease, hypothyroidism, diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis |
| 04/25/2002 | US20020049225 Quinuclidine-substituted aryl compounds for treatment of disease |
| 04/25/2002 | US20020049224 Alpha v integrin receptor antagonists |
| 04/25/2002 | US20020049222 Cyclopentyl modulators of chemokine receptor activity |
| 04/25/2002 | US20020049221 Analogs of deoxypreussomerin, palmarumycin CPI and related naphthoquinone spiroketals; inhibit thioredoxin-thioredoxin reductase system |
| 04/25/2002 | US20020049220 Substituted azoles |
| 04/25/2002 | US20020049218 2-, 6, and 9-substituted purine derivatives, particularly 2(1-R hydroxymethylpropylamino)-6-benzylamino-9-isopropyl purine, used as drug and herbicide; inhibiting effect with respect to cyclin-dependent kinase proteins |
| 04/25/2002 | US20020049215 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 04/25/2002 | US20020049214 Aralkyl and aralkylidene heterocyclic lactams and imides as selective agonists and antagonists of serotonin 1 (5-HT1) recepor, used in treating hypertension and all forms of depression |
| 04/25/2002 | US20020049212 Benzimidazole compounds and salts containing piperidine ring are useful in treatment or prevention or medical conditions selected from pain, and inflammatoy diseases; analgesics |
| 04/25/2002 | US20020049211 Combination treatment for depression and anxiety |
| 04/25/2002 | US20020049210 Heteroaryl amines as novel acetylcholinesterase inhibitors |
| 04/25/2002 | US20020049209 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
| 04/25/2002 | US20020049208 Imidazo[1,2-a]pyrazines for the treatment of neurological disorders |
| 04/25/2002 | US20020049207 Nitrogen containing heterobicyclic compounds for treating disorders manifesting hypersecretion of corticotropin releasign factor(CRF) in a warm-blooded animals, such as stroke |
| 04/25/2002 | US20020049206 Compounds for the treatment of addictive disorders |
| 04/25/2002 | US20020049205 Pyrazole antimicrobial agents |
| 04/25/2002 | US20020049204 1,4-dihydro-benzo(d)oxazin-2-one derivatives useful for treating hormone-dependent neoplastic disease is selected from uterine myometrial fibroids, endometriosis, benign prostatic hypertrophy, carcinomas, and adenocarcinoma |
| 04/25/2002 | US20020049203 CRF receptor antagonists and methods relating thereto |
| 04/25/2002 | US20020049202 Administering halogenated amidino or oxyamidino compound to treat diseases caused by nitric oxide synthase |
| 04/25/2002 | US20020049200 Use of a methylol-containing compound to treat tumors |
| 04/25/2002 | US20020049199 N-linked carbamates and ureas of heterocyclic thioesters |
| 04/25/2002 | US20020049198 Administering to a patient having or at risk of having osteoarthritis, a therapeutically effective amount of an bicyclicaromatic or heteroaromatic compound containing amine and hydroxy groups |
| 04/25/2002 | US20020049197 Aminoquinazolines and their use as medicaments |
| 04/25/2002 | US20020049196 Hexahydro-pyrazolo-(4,3-c)pyridine derivatives useful for increasing the endogenous production or release of growth hormone in a human or other animal, thus treat or prevent osteoporosis |
| 04/25/2002 | US20020049195 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc. |
| 04/25/2002 | US20020049194 A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist |
| 04/25/2002 | US20020049193 Inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity. |
| 04/25/2002 | US20020049190 Useful in binding nitric oxide; inhibiting tumor growth |
| 04/25/2002 | US20020049189 Vanadium (IV) complexes containing catecholate ligand and having spermicidal activity |
| 04/25/2002 | US20020049188 Relieving pain associated with anal fissures. |
| 04/25/2002 | US20020049186 Phenylazophenylacetic acid derivatives; treating inflammatory bowel disease |
| 04/25/2002 | US20020049185 Malonic acid based matrix metalloproteinase inhibitors |
| 04/25/2002 | US20020049183 Phospholipids, espeically phosphatidylethanolamines, covalently bound to physiologically acceptable monomers or polymers. |
| 04/25/2002 | US20020049182 Administering to a mammal a composition containing pyrimidine nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory chain deficiencies. |
| 04/25/2002 | US20020049180 KIAA0175 inhibitor is selected from the group consisting of an anti-sense molecule, a ribozyme, an antibody, an antibody fragment, a protein, a polypeptide and a small molecule. |
| 04/25/2002 | US20020049177 Detecting an aberrant level or bioactivity of or screening for a Wnt pathway component or a frizzled related protein gene product |
| 04/25/2002 | US20020049174 First region is available for hybridization and the second region is temporarily masked. |
| 04/25/2002 | US20020049172 Chlamydia oligosaccharides |
| 04/25/2002 | US20020049171 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria |
| 04/25/2002 | US20020049170 Method for reducing toxicity of combined chemotherapies |
| 04/25/2002 | US20020049169 Administration of 7-methylthiomethyl taxol and doxorubicin |
| 04/25/2002 | US20020049167 Azithromycin as a therapeutic agent for infections with leishmania parasites |
| 04/25/2002 | US20020049166 Antineoplastic agents and antioxidants; preservative and topiosomerase-inhibiting compositions |
| 04/25/2002 | US20020049161 Especially Fe(III) saccharate and gluconate; treatment of hemodialysis patients. |